- Login
- Register & Subscribe
- Language: EN FR DE
Regenerative Medicine
Evotec in diabetes research deal
Thursday 10 March 2011
Evotec AG has announced the establishment of a research collaboration with Harvard University and the Howard Hughes Medical Institute in the US to discover and develop new treatments for diabetes. Financial terms were not disclosed.
Location
Germany
Généthon and Wake Forest collaborate on gene therapy project
Tuesday 8 March 2011
Généthon, a not-for profit French biotherapy laboratory, has announced a collaboration with the Wake Forest University School of Medicine in the US to work on the preclinical development of a gene therapy for myotubular myopathy.
Location
France
Scientists report transforming stem cells into neurons critical for memory
Saturday 5 March 2011
Scientists from the Northwestern University Feinberg School of Medicine in the US have reported transforming human embryonic stem cells into a type of neuron that plays a critical role in memory. The findings have been published in Stem Cells.
Location
United States
Molecular switch for epidermal stem cells reported
Thursday 3 March 2011
Researchers at Children’s Hospital in Boston, Massachusetts have reported finding a regulator of gene activity that can instruct epidermal stem cells to grow or stop growing, a finding that may have use for cancer as well as regenerative medicine.
Location
United States
Renovo restructures following trial failure
Thursday 3 March 2011
The Renovo Group Plc is reducing its staff and the size of its board of directors in the wake of the failure of a Phase 3 trial of its wound-healing product, Juvista. Recruitment is also being stopped for a trial of a second tissue product.
Location
United Kingdom
TiGenix to merge with Spanish stem-cell company
Friday 25 February 2011
TiGenix NV of Belgium and Cellerix SA of Spain have agreed to merge creating what is expected to be the largest cell therapy and regenerative medicine company in Europe. It is the most significant corporate transaction in the field of regenerative medicine since the December 2010 alliance between Cephalon Inc and Mesoblast Ltd of Australia
Location
Belgium
Change of management at Fate Therapeutics
Tuesday 22 February 2011
Fate Therapeutics Inc, the San Diego, California-based stem cell company, has announced the departure of its president and chief executive officer, Paul Grayson. Mr Grayson is leaving to form a new company, according to Fate.
Location
United States
Dutch to finance study of stem cells for transplants
Friday 18 February 2011
Three Dutch organisations are allocating more than €3 million to a project that will develop a method for culturing stem cells for transplants in leukaemia patients. The study will also develop imaging technology to monitor these treatments.
Location
Netherlands
Regulatory considerations for stem cell-based products published
Thursday 17 February 2011
The European Medicines Agency has issued new advice on the procedures that companies should follow in developing stem cell products. The advice is contained in a paper on the agency’s website, www.ema.europa.eu. (EMA/CAT/571134/2009).
Location
United Kingdom
Lilly and JDRF to research strategy for beta-cell regeneration
Friday 4 February 2011
Eli Lilly and Company has entered into a three-year research agreement with the Juvenile Diabetes Research Foundation to explore a new strategy for regenerating beta cells in people with Type 1 diabetes.
Location
United States
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013